Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells

doi:10.1083/jcb.105.6.2535

PeproTech: Your source for Cell Biology Research Reagents

This Article

	Full Text (PDF, 3310K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Pepper, M. S.
	Articles by Orci, L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Pepper, M. S.
	Articles by Orci, L.


Social Bookmarking

	What's this?

ARTICLES

Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells

MS Pepper, JD Vassalli, R Montesano and L Orci
Institute of Histology and Embryology, University of Geneva Medical Center, Switzerland.

Cellular migration is an essential component of invasive biological processes, many of which have been correlated with an increase in plasminogen activator production. Endothelial cell migration occurs in vivo during repair of vascular lesions and angiogenesis, and can be induced in vitro by wounding a confluent monolayer of cells. By combining the wounded monolayer model with a substrate overlay technique, we show that cells migrating from the edges of an experimental wound display an increase in urokinase-type plasminogen activator (uPA) activity, and that this activity reverts to background levels upon cessation of movement, when the wound has closed. Our results demonstrate a direct temporal relationship between endothelial cell migration and uPA activity, and suggest that induction of uPA activity is a component of the migratory process.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Ivanciu, L., Gerard, R. D., Tang, H., Lupu, F., Lupu, C. (2007). Adenovirus-Mediated Expression of Tissue Factor Pathway Inhibitor-2 Inhibits Endothelial Cell Migration and Angiogenesis. Arterioscler. Thromb. Vasc. Bio. 27: 310-316 [Abstract] [Full Text]
Panopoulou, E., Murphy, C., Rasmussen, H., Bagli, E., Rofstad, E. K., Fotsis, T. (2005). Activin A Suppresses Neuroblastoma Xenograft Tumor Growth via Antimitotic and Antiangiogenic Mechanisms. Cancer Res. 65: 1877-1886 [Abstract] [Full Text]
Providence, K. M., White, L. A., Tang, J., Gonclaves, J., Staiano-Coico, L., Higgins, P. J. (2002). Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene. J. Cell Sci. 115: 3767-3777 [Abstract] [Full Text]
Samarakoon, R., Higgins, P. J. (2002). MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks. J. Cell Sci. 115: 3093-3103 [Abstract] [Full Text]
Tille, J.-C., Wood, J., Mandriota, S.J., Schnell, C., Ferrari, S., Mestan, J., Zhu, Z., Witte, L., Pepper, M. S. (2001). Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro. J. Pharmacol. Exp. Ther. 299: 1073-1085 [Abstract] [Full Text]
Pepper, M. S. (2001). Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis. Arterioscler. Thromb. Vasc. Bio. 21: 1104-1117 [Abstract] [Full Text]
Kutz, S. M., Hordines, J., McKeown-Longo, P. J., Higgins, P. J. (2001). TGF-{beta}1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J. Cell Sci. 114: 3905-3914 [Abstract] [Full Text]
Frandsen, T. L., Holst-Hansen, C., Nielsen, B. S., Christensen, I. J., Nyengaard, J. R., Carmeliet, P., Brünner, N. (2001). Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model. Cancer Res. 61: 532-537 [Abstract] [Full Text]
Martini, J.-F., Piot, C., Humeau, L. M., Struman, I., Martial, J. A., Weiner, R. I. (2000). The Antiangiogenic Factor 16K PRL Induces Programmed Cell Death in Endothelial Cells by Caspase Activation. Mol. Endocrinol. 14: 1536-1549 [Abstract] [Full Text]
Gutierrez, L. S., Schulman, A., Brito-Robinson, T., Noria, F., Ploplis, V. A., Castellino, F. J. (2000). Tumor Development Is Retarded in Mice Lacking the Gene for Urokinase-Type Plasminogen Activator or Its Inhibitor, Plasminogen Activator Inhibitor-1. Cancer Res. 60: 5839-5847 [Abstract] [Full Text]
Wilson, A J, Gibson, P R (2000). Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro. Gut 47: 105-111 [Abstract] [Full Text]
Lee, H., Struman, I., Clapp, C., Martial, J., Weiner, R. I. (1998). Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression. Endocrinology 139: 3696-3703 [Abstract] [Full Text]
Tang, H., Kerins, D. M., Hao, Q., Inagami, T., Vaughan, D. E. (1998). The Urokinase-type Plasminogen Activator Receptor Mediates Tyrosine Phosphorylation of Focal Adhesion Proteins and Activation of Mitogen-activated Protein Kinase in Cultured Endothelial Cells. J. Biol. Chem. 273: 18268-18272 [Abstract] [Full Text]
Bochaton-Piallat, M.-L., Gabbiani, G., Pepper, M. S. (1998). Plasminogen Activator Expression in Rat Arterial Smooth Muscle Cells Depends on Their Phenotype and Is Modulated by Cytokines. Circ. Res. 82: 1086-1093 [Abstract] [Full Text]
Quax, P. H. A., Grimbergen, J. M., Lansink, M., Bakker, A. H. F., Blatter, M.-C., Belin, D., van Hinsbergh, V. W. M., Verheijen, J. H. (1998). Binding of Human Urokinase-Type Plasminogen Activator to Its Receptor : Residues Involved in Species Specificity and Binding. Arterioscler. Thromb. Vasc. Bio. 18: 693-701 [Abstract] [Full Text]
Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P. C., Binder, B. R. (1997). Urokinase Receptor Is Associated with the Components of the JAK1/STAT1 Signaling Pathway and Leads to Activation of This Pathway upon Receptor Clustering in the Human Kidney Epithelial Tumor Cell Line TCL-598. J. Biol. Chem. 272: 28563-28567 [Abstract] [Full Text]
Herbert, J.-M., Lamarche, I., Carmeliet, P. (1997). Urokinase and Tissue-type Plasminogen Activator Are Required for the Mitogenic and Chemotactic Effects of Bovine Fibroblast Growth Factor and Platelet-derived Growth Factor-BB for Vascular Smooth Muscle Cells. J. Biol. Chem. 272: 23585-23591 [Abstract] [Full Text]
Yu, W., Kim, J., Ossowski, L. (1997). Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy. JCB 137: 767-777 [Abstract] [Full Text]
Jenkins, G. R., Seiffert, D., Parmer, R. J., Miles, L. A. (1997). Regulation of Plasminogen Gene Expression by Interleukin-6. Blood 89: 2394-2403 [Abstract] [Full Text]
Schaper, W., Ito, W. D. (1996). Molecular Mechanisms of Coronary Collateral Vessel Growth. Circ. Res. 79: 911-919 [Full Text]
Reidy, M. A., Irvin, C., Lindner, V. (1996). Migration of Arterial Wall Cells : Expression of Plasminogen Activators and Inhibitors in Injured Rat Arteries. Circ. Res. 78: 405-414 [Abstract] [Full Text]
Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., R, J., Solberg, H., Ellis, V., Dan�, K., Degen, J. L. (1995). The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility. J. Biol. Chem. 270: 16886-16894 [Abstract] [Full Text]
Mandriota, S. J., Seghezzi, G., Vassalli, J.-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., Pepper, M. S. (1995). Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells. J. Biol. Chem. 270: 9709-9716 [Abstract] [Full Text]
Kojima, S., Muramatsu, H., Amanuma, H., Muramatsu, T. (1995). Midkine Enhances Fibrinolytic Activity of Bovine Endothelial Cells. J. Biol. Chem. 270: 9590-9596 [Abstract] [Full Text]
Bugge, T H, Flick, M J, Daugherty, C C, Degen, J L (1995). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.. Genes Dev. 9: 794-807 [Abstract]
Morales, D. E., McGowan, K. A., Grant, D. S., Maheshwari, S., Bhartiya, D., Cid, M. C., Kleinman, H. K., Schnaper, H. W. (1995). Estrogen Promotes Angiogenic Activity in Human Umbilical Vein Endothelial Cells In Vitro and in a Murine Model. Circulation 91: 755-763 [Abstract] [Full Text]
Pepper, M., Ferrara, N, Orci, L, Montesano, R (1995). Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J. Cell Sci. 108: 73-83 [Abstract]
Brenner, C A, Adler, R R, Rappolee, D A, Pedersen, R A, Werb, Z (1989). Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development.. Genes Dev. 3: 848-859 [Abstract]